MJ MEDTECH finished psilocybin extract in vivo animal trials

Written by ITW

November 25, 2020

Two years ago South African company MJ MEDTECH a subsidiary of WUHAN GENERAL GROUP INC. announced plans to enter psychedelic sector after successful cannabis and CBD endeavors. Tests are now complete for Rat and cell line trials with the focus now being pushed towards analyzing the data and putting it into meaningful words that can show the true applications of psilocybin. They are testing for brain chemistry, inflammation, overall health and long term affects. The goal of these studies is to prove the efficacy of psilocybin as a treatment for mental health (ptsd, depression, anxiety, etc) as well as other physical ailments (high blood pressure, brain inflammation etc). Human trials are now being scheduled in accordance with Covid 19 limitations. They currently have several successful cannabis products and will follow suit with extracts and fruiting bodies  when testing is complete.

Related Articles

Flower mimic

Flower mimic

On a collection trip to Guyana in 2006, botanist Kenneth Wurdack was strolling along an airstrip at Kaieteur National Park when he noticed something unusual about the flowers on two species of yellow-eyed grasses. Unlike the species’ typical blooms, they were a more...

Epiphytes: the Inside Scoop

Epiphytes: the Inside Scoop

Fungi are everywhere—they grow in the soil, in petri dishes, and if we’re not careful, on the fruit in the back of the fridge. But did you know it can grow inside plants too? Yes, really! Of course, there are fungal pathogens, which can parasitize a plant, sometimes...

Stay Up to Date With The Latest News & Updates